Literature DB >> 7931191

Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease.

G Pozzato1, S Kaneko, M Moretti, L S Crocè, F Franzin, M Unoura, L Bercich, C Tiribelli, M Crovatto, G Santini.   

Abstract

The presence of the "Japanese type" NS4 region was investigated in two series of patients (53 from Italy and 58 from Japan) with hepatitis C virus (HCV)-related chronic liver disease. The two populations were homogeneous as regard to age, male/female ratio, histological diagnosis, and serum aminotransferase activities. Genomic amplification was carried out by "nested" polymerase chain reaction (PCR) with a pair of primers synthesized according to the sequence of JK-1 isolated in Japan. The presence of viral replication was confirmed further by PCR amplification of the 5'NC region. The NS4 region of the Japanese strain was detected in 24 sera (45%) from Italy and in 44 (71%) from Japan. NS4-positive patients were significantly older and showed an ALT serum level significantly lower (P < 0.01) than NS4 negative cases in each group. Cirrhosis was significantly (P < 0.0007) more common in NS4-positive than in NS4-negative patients. The HCV genotype was subsequently obtained according to Okamoto. All the NS4-positive patients were infected by Type II, whereas in NS4-negative patients all four genotypes were present though Type II still constituted the majority. Cirrhosis was associated exclusively with Type II both in NS4-positive and -negative subjects. These data indicate that, although the positivity for NS4 "Japanese" region seems to be associated with a more aggressive liver disease, the most prevalent Type II predicts more specifically those who are likely to develop cirrhosis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931191     DOI: 10.1002/jmv.1890430318

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  22 in total

1.  Predominance of hepatitis C virus genotype 1b in Bulgaria.

Authors:  A Andonov; P Teoharov; S Bakalova
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

2.  Comparison of DNA enzyme immunoassay and line probe assays (Inno-LiPA HCV I and II) for hepatitis C virus genotyping.

Authors:  S Le Pogam; F Dubois; R Christen; C Raby; A Cavicchini; A Goudeau
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

3.  Concordance of hepatitis C virus typing methods based on restriction fragment length polymorphism analysis in 5' noncoding region and NS4 serotyping, but not in core PCR or a line probe assay.

Authors:  S Navas; I Castillo; J Martín; J A Quiroga; J Bartolomé; V Carreño
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

4.  Genotyping of hepatitis C virus in South Africa.

Authors:  H E Smuts; J Kannemeyer
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

5.  Impact of hepatitis B and hepatitis C virus infections in a hematology-oncology unit at a children's hospital in Nicaragua, 1997 to 1999.

Authors:  Kirsten Visoná; Fulgencio Baez; Lizeth Taylor; René Berríos; Bernal León; Carlos Pacheco; Roberto Jirón; Ronald B Luftig; M Mercedes Somarriba
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

6.  Analysis of hepatitis C virus isolates by serotyping and genotyping.

Authors:  L J van Doorn; B Kleter; I Pike; W Quint
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

7.  Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients.

Authors:  E Villa; P Buttafoco; A Merighi; A Grottola; I Ferretti; A Ferrari; F Callea; P Trande; A M Rebecchi; F Manenti
Journal:  J Mol Med (Berl)       Date:  1995-05       Impact factor: 4.599

Review 8.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

9.  Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan.

Authors:  Abbas Ali Husseini; Khwaja Mir Islam Saeed; Esra Yurdcu; A Mithat Bozdayı
Journal:  Turk J Gastroenterol       Date:  2020-09       Impact factor: 1.852

10.  Hepatitis C virus (HCV) genotyping by annealing reverse transcription-PCR products with genotype-specific capture probes.

Authors:  Jungmin Rho; Jong Soon Ryu; Wonhee Hur; Chang Wook Kim; Jeong Won Jang; Si Hyun Bae; Jong Young Choi; Sung Key Jang; Seung Kew Yoon
Journal:  J Microbiol       Date:  2008-02       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.